8 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
PAMI) - Opioid Prescribing ... Chart - Agents and Dosing ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Angiotensin Receptor ... Recommended Dose Conversions ... class is still going ... #Angiotensin #Receptor ... #Table #Dosing
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... Products Insulin dosing ... Insulin #Basics #Dosing ... #Conversion #Initiating ... #Prescribing #Pharmacology
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Angiotensin II Receptor ... ARB #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII ... #Receptor #Blocker
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
Hypersensitivity Types ... cells via their Fc receptor ... or during hemolytic ... #Classification ... Diagnosis #Reactions #Table
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... If patient is stable ... Buprenorphine Dosing ... chronic pain split dosing ... #Addiction #Prescribing
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANGIOTENSIN II RECEPTOR ... ANTAGONIST (ARB) DOSING ... angiotensin II receptor ... #Pharmacology #Conversion ... Switching #Equivalent #Table
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Kikuchi disease • Type-I ... pancreatitis, protein-losing ... Antineuronal, Anti-NMDA receptor